PL366197A1 - Leczenie zaburzeń lękowych - Google Patents

Leczenie zaburzeń lękowych

Info

Publication number
PL366197A1
PL366197A1 PL99366197A PL36619799A PL366197A1 PL 366197 A1 PL366197 A1 PL 366197A1 PL 99366197 A PL99366197 A PL 99366197A PL 36619799 A PL36619799 A PL 36619799A PL 366197 A1 PL366197 A1 PL 366197A1
Authority
PL
Poland
Prior art keywords
treatment
anxiety disorders
anxiety
disorders
Prior art date
Application number
PL99366197A
Other languages
English (en)
Inventor
Lee Alan Phebus
Tammy Joy Sajdyk
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL366197A1 publication Critical patent/PL366197A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL99366197A 1998-07-27 1999-07-08 Leczenie zaburzeń lękowych PL366197A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9431098P 1998-07-27 1998-07-27
PCT/US1999/015475 WO2000006082A2 (en) 1998-07-27 1999-07-08 Treatment of anxiety disorders

Publications (1)

Publication Number Publication Date
PL366197A1 true PL366197A1 (pl) 2005-01-24

Family

ID=22244420

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99366197A PL366197A1 (pl) 1998-07-27 1999-07-08 Leczenie zaburzeń lękowych

Country Status (14)

Country Link
EP (1) EP0976747A3 (pl)
JP (1) JP2003527305A (pl)
KR (1) KR20010072064A (pl)
CN (1) CN1315830A (pl)
AU (1) AU4977899A (pl)
BR (1) BR9913348A (pl)
CA (1) CA2338740A1 (pl)
EA (1) EA200100182A1 (pl)
HU (1) HUP0102886A3 (pl)
IL (1) IL140540A0 (pl)
NO (1) NO20010390L (pl)
PL (1) PL366197A1 (pl)
TR (1) TR200100240T2 (pl)
WO (1) WO2000006082A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844344B2 (en) 1999-12-20 2005-01-18 Eli Lilly And Company Benzofuran derivatives
DE60026581T2 (de) * 1999-12-20 2006-12-28 Eli Lilly And Co., Indianapolis Indolderivate zur behandlung von depression und angstzuständen
AU2251801A (en) * 1999-12-20 2001-07-03 Eli Lilly And Company Piperidine derivatives and their use as serotonin receptor antagonists
US20080319209A1 (en) * 2005-02-17 2008-12-25 Guozhi Wang Process for Preparing (Disubstitutedpropenyl) Phenylalkyl Substituted Dihydrobenzofurans
EP1853577A4 (en) * 2005-02-17 2009-02-18 Bayer Cropscience Ag IMPROVED PROCESS FOR THE PREPARATION OF (DISUBSTITUTED PROPENYL) PHENYL ALKYL SUBSTITUTED DIHYDROBENZOFURANES
CN101146788A (zh) * 2005-03-23 2008-03-19 拜尔农作物科学股份公司 改进的制备具有杀虫作用的（二取代丙烯基）苯基烷基取代的二氢苯并呋喃的方法
CN107973766B (zh) * 2016-10-21 2020-06-19 石家庄诚志永华显示材料有限公司 含有环烷基的氧芴衍生物的液晶化合物及其应用
TWI744458B (zh) * 2017-02-27 2021-11-01 日商捷恩智股份有限公司 具有二苯并呋喃環的化合物、液晶組成物及液晶顯示元件

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2941597A1 (de) * 1979-10-13 1981-04-23 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists

Also Published As

Publication number Publication date
EP0976747A2 (en) 2000-02-02
NO20010390L (no) 2001-03-13
NO20010390D0 (no) 2001-01-23
TR200100240T2 (tr) 2002-01-21
WO2000006082A3 (en) 2000-05-04
JP2003527305A (ja) 2003-09-16
BR9913348A (pt) 2001-06-12
WO2000006082A2 (en) 2000-02-10
AU4977899A (en) 2000-02-21
HUP0102886A2 (en) 2002-06-29
EA200100182A1 (ru) 2001-08-27
KR20010072064A (ko) 2001-07-31
CA2338740A1 (en) 2000-02-10
HUP0102886A3 (en) 2002-12-28
CN1315830A (zh) 2001-10-03
EP0976747A3 (en) 2000-09-13
IL140540A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
EP1063990A4 (en) THERAPY FOR ESTROGEN RELATED DISORDERS
GB0007193D0 (en) Treatment of movrmrnt disorders
HRP990195B1 (en) Intranasal formulations for the treatment of sexual disorders
PL348817A1 (en) Compositions and methods for the treatment of anorectal disorders
HUP0400914A3 (en) Methods of treatment of mitochondrial disorders
PL339425A1 (en) Treatment of behavioural disorders
GB9824436D0 (en) Methods of treatment
IL141263A0 (en) Methods for treatment of neurological disorders
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
IL146131A0 (en) Treatment of neurotic disorders
EP1126850A4 (en) TREATMENT OF CONDITIONS OF THE RETINA
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
GB9926968D0 (en) Treatment of neurological disorders
IL155874A0 (en) Treatment of anxiety disorders
IL140540A0 (en) Treatment of anxiety disorders
AU3757300A (en) Method of treating anxiety disorders
CZ20011872A3 (cs) Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
IL131347A0 (en) Treatment of skin disorders
IL126681A0 (en) Treatment of trauma-related conditions
GB0010496D0 (en) Treatment of conditions of the central nervous system
GB9815188D0 (en) Treatment of skin disorders
GB9821610D0 (en) Treatment of neuropsychiatric disorders
GB9816349D0 (en) The treatment of inflammatory disorders
GB9816352D0 (en) The treatment of inflammatory disorders
GB9727001D0 (en) Treatment of movement disorders

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)